Latest AI and machine learning research in dementia for healthcare professionals.
INTRODUCTION: In 2024, 11 European scientific societies/organizations and one patient advocacy association have defined a patient-centered biomarker-based diagnostic workflow for memory clinics evaluating neurocognitive disorders.
Diagnosing Alzheimer's disease based on gene expression data extracted from microarrays is still an open field of research. Due to the availability of whole-genome data through microarrays technology, diagnosis accuracy is expected to be improved. Despite the high potential of the data prepared by the technology, their analysis on different platforms shows that they may differ for different sample...
The recent approval of anti-amyloid pharmaceuticals for the treatment of Alzheimer's disease (AD) has created a pressing need for the ability to accur...
Single-cell RNA sequencing has demonstrated that the presence of parenchymal amyloid plaques and intracellular hyperphosphorylated tau pathology is as...
Alzheimer's disease (AD) is a neurodegenerative disorder that affects memory and cognitive functions. Manual diagnosis is prone to human error, often ...
BACKGROUND: The study aimed to explore the applicability of plasma phosphorylated tau (p-tau)217 in identifying patients with subjective cognitive dec...
Dementia represents a global public health concern, with the early detection of Alzheimer's disease, the most prevalent form of dementia, being of par...
Fine particulate matter (PM) is recognized as one of the most harmful environmental pollutants to human health. Current research indicates that PM exh...
Timely intervention for Alzheimer's disease (AD) requires early detection. The development of immunotherapies targeting amyloid-beta and tau underscor...
In the context of lifestyle changes, stress and other environmental factors have resulted in the sudden hike in dementia globally. This necessitates i...
BackgroundLanguage deficits often occur early in the neurodegenerative process, yet traditional methods frequently fail to detect subtle changes. Natu...
In this pioneering study, inspired by AutoGPT, the state-of-the-art open-source application based on the GPT-4 large language model, we develop a nove...
One of the areas where artificial intelligence (AI) technologies are used is the detection and diagnosis of mental disorders. AI approaches, including...
BACKGROUND: Systemically identifying caregivers in the electronic health record (EHR) is a critical step for delivering patient-centered care, enhanci...
To improve the identification of cognitive impairment by distinguishing normal cognition (NC), mild cognitive impairment (MCI), and Alzheimer's disea...
BackgroundDancing may be protective for cognitive health among adults with mild cognitive impairment, Alzheimer's disease or dementia; however, additi...
BACKGROUND: Population aging increases the economic burden of Alzheimer's disease (AD). Early screening for mild cognitive impairment (MCI) has the po...
Ensemble learning (EL), a machine learning technique that combines the results of multiple learning algorithms to obtain predicted values, aims to ach...
BACKGROUND: Goals of care (GOC) conversations are an evidence-based practice that help clarify and align patient values and preferences for medical ca...
Mild cognitive impairment (MCI) represents an early stage of Alzheimer's disease (AD), characterized by subtle clinical symptoms that pose challenges ...